ENTITY
Kangmei Pharmaceutical Co Ltd

Kangmei Pharmaceutical Co Ltd (600518 CH)

34
Analysis
Health Care • China
Kangmei Pharmaceutical Co., Ltd. develops, produces, and sells medicines that are used for the treatment of high blood pressure and cold. The Company also pr oduces antibiotic drugs and health care products. Kangmei also sells other manufacturers' medical products through its wholesale and retail chain.
more
bullish•Luckin Coffee
•08 Jul 2021 01:30

Tougher Chinese Regulatory Oversight of Foreign Listed Chinese Companies (With Caveats)

Chinese regulators just introduced guidelines for crackdown on capital markets misconduct, the latest one-two punch following the Didi debacle. ...

Share
bullish•Macroeconomics
•06 May 2019 04:33

Trade War/Huawei/Financial Risks/Mr Science & Mr Democracy

China News That Matters Concessions all round in US-China trade talks Huawei “stealing its way” to global dominance? Consumers flip credit cards...

Share
•05 Mar 2019 11:25

Shanghai/Shenzhen Connect - $8.4 Bn Inflows in February (Kweichow Moutai, Aier Eye, Luxshare)

In our Discover SZ/SH Connect series, we aim to help our investors understand the flow of northbound trades via the Shanghai Connect and Shenzhen...

Logo
508 Views
Share
•09 Oct 2017 16:15

Global Pharmaceuticals: Valuations, Assets and Leverage Up - Margins Down

We examined ten years of accounting and valuation data for the pharmaceutical companies around the world with sales of US$100m+ and created...

•09 Feb 2017 09:14

Trump Health Effect: What Is Next for the Consumer Health Industry Under Trump's Leadership?

While the US consumer health industry will remain a strong centre for investment, development and technology innovation in 2017 and is expected to...

x